Pharmaceutical

ProofPilot and Legacy Health Strategies Partner to Scale Patient Engagement Strategies Beyond the Trial

NEW YORK, Sept. 14, 2023 /PRNewswire/ -- ProofPilot, a leading provider of innovative clinical trial automation, and Legacy Health Strategies,…

10 months ago

Labcorp to Present Strategy, Business and Financial Outlook at Investor Day

BURLINGTON, N.C., Sept. 14, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting…

10 months ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union

The positive opinion follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines for…

10 months ago

Mayo Clinic and GE HealthCare Enter Strategic Collaboration to Advance Innovation in Medical Imaging and Theranostics

Combining the world-class clinical and research expertise of Mayo Clinic with the deep research, engineering, and product development expertise of…

10 months ago

Jaguar Health Shares Presentation Replay Link from September 11-13, 2023 H.C. Wainwright Annual Global Investment Conference

Click here to access webcast replayTop line results expected late October 2023 for company's phase 3 OnTarget trial of crofelemer…

10 months ago

Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry

The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to Highly Complex Assays Cytek Reveal…

10 months ago

Rencofilstat Produces Positive Outcomes in Translational Study on Idiopathic Pulmonary Fibrosis

– Proteomics analysis showed that rencofilstat improved aberrant protein profiles in IPF tissues – – Superior effects of rencofilstat alone…

10 months ago

OKYO Pharma Limited Announces Withdrawal of Public Offering

LONDON and NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an…

10 months ago

Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI®

SOLANA BEACH, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on…

10 months ago